001     138890
005     20240321220522.0
024 7 _ |a 10.1002/ana.24758
|2 doi
024 7 _ |a pmid:27518166
|2 pmid
024 7 _ |a 0364-5134
|2 ISSN
024 7 _ |a 1531-8249
|2 ISSN
024 7 _ |a altmetric:10445834
|2 altmetric
037 _ _ |a DZNE-2020-05212
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Baykara, Ebru
|b 0
245 _ _ |a A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms.
260 _ _ |a Hoboken, NJ
|c 2016
|b Wiley-Blackwell
264 _ 1 |3 online
|2 Crossref
|b Wiley
|c 2016-08-29
264 _ 1 |3 print
|2 Crossref
|b Wiley
|c 2016-10-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1588260841_17521
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a To establish a fully automated, robust imaging marker for cerebral small vessel disease (SVD) and related cognitive impairment that is easy to implement, reflects disease burden, and is strongly associated with processing speed, the predominantly affected cognitive domain in SVD.We developed a novel magnetic resonance imaging marker based on diffusion tensor imaging, skeletonization of white matter tracts, and histogram analysis. The marker (peak width of skeletonized mean diffusivity [PSMD]) was assessed along with conventional SVD imaging markers. We first evaluated associations with processing speed in patients with genetically defined SVD (n = 113). Next, we validated our findings in independent samples of inherited SVD (n = 57), sporadic SVD (n = 444), and memory clinic patients with SVD (n = 105). The new marker was further applied to healthy controls (n = 241) and to patients with Alzheimer's disease (n = 153). We further conducted a longitudinal analysis and interscanner reproducibility study.PSMD was associated with processing speed in all study samples with SVD (p-values between 2.8 × 10(-3) and 1.8 × 10(-10) ). PSMD explained most of the variance in processing speed (R(2) ranging from 8.8% to 46%) and consistently outperformed conventional imaging markers (white matter hyperintensity volume, lacune volume, and brain volume) in multiple regression analyses. Increases in PSMD were linked to vascular but not to neurodegenerative disease. In longitudinal analysis, PSMD captured SVD progression better than other imaging markers.PSMD is a new, fully automated, and robust imaging marker for SVD. PSMD can easily be applied to large samples and may be of great utility for both research studies and clinical use. Ann Neurol 2016;80:581-592.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
542 _ _ |i 2015-09-01
|2 Crossref
|u http://doi.wiley.com/10.1002/tdm_license_1.1
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Biomarkers
|2 NLM Chemicals
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Aged, 80 and over
|2 MeSH
650 _ 2 |a Alzheimer Disease: diagnostic imaging
|2 MeSH
650 _ 2 |a Biomarkers
|2 MeSH
650 _ 2 |a Cerebral Small Vessel Diseases: complications
|2 MeSH
650 _ 2 |a Cerebral Small Vessel Diseases: diagnostic imaging
|2 MeSH
650 _ 2 |a Cognitive Dysfunction: diagnostic imaging
|2 MeSH
650 _ 2 |a Cognitive Dysfunction: etiology
|2 MeSH
650 _ 2 |a Cognitive Dysfunction: physiopathology
|2 MeSH
650 _ 2 |a Diffusion Tensor Imaging: methods
|2 MeSH
650 _ 2 |a Diffusion Tensor Imaging: standards
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Reproducibility of Results
|2 MeSH
650 _ 2 |a White Matter: diagnostic imaging
|2 MeSH
650 _ 2 |a Young Adult
|2 MeSH
700 1 _ |a Gesierich, Benno
|b 1
700 1 _ |a Adam, Ruth
|b 2
700 1 _ |a Tuladhar, Anil Man
|b 3
700 1 _ |a Biesbroek, J Matthijs
|b 4
700 1 _ |a Koek, Huiberdina L
|b 5
700 1 _ |a Ropele, Stefan
|b 6
700 1 _ |a Jouvent, Eric
|b 7
700 1 _ |a Initiative, Alzheimer's Disease Neuroimaging
|b 8
700 1 _ |a Chabriat, Hugues
|b 9
700 1 _ |a Ertl-Wagner, Birgit
|b 10
700 1 _ |a Ewers, Michael
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Schmidt, Reinhold
|0 P:(DE-HGF)0
|b 12
700 1 _ |a de Leeuw, Frank-Erik
|b 13
700 1 _ |a Biessels, Geert Jan
|b 14
700 1 _ |a Dichgans, Martin
|0 P:(DE-2719)2000030
|b 15
|u dzne
700 1 _ |a Duering, Marco
|0 P:(DE-HGF)0
|b 16
|e Corresponding author
773 1 8 |a 10.1002/ana.24758
|b : Wiley, 2016-08-29
|n 4
|p 581-592
|3 journal-article
|2 Crossref
|t Annals of Neurology
|v 80
|y 2016
|x 0364-5134
773 _ _ |a 10.1002/ana.24758
|g Vol. 80, no. 4, p. 581 - 592
|0 PERI:(DE-600)2037912-2
|n 4
|q 80:4<581 - 592
|p 581-592
|t Annals of neurology
|v 80
|y 2016
|x 0364-5134
909 C O |o oai:pub.dzne.de:138890
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 15
|6 P:(DE-2719)2000030
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|2 G:(DE-HGF)POF3-300
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2016
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ANN NEUROL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b ANN NEUROL : 2017
920 1 _ |0 I:(DE-2719)1111016
|k Clinical Dementia Research München
|l Clinical Dementia Research München
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1111016
980 _ _ |a UNRESTRICTED
999 C 5 |a 10.1016/S1474-4422(10)70104-6
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/S1474-4422(10)70104-6
999 C 5 |a 10.1016/S1474-4422(13)70124-8
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/S1474-4422(13)70124-8
999 C 5 |a 10.1161/JAHA.114.001140
|9 -- missing cx lookup --
|2 Crossref
|o 10.1161/JAHA.114.001140
999 C 5 |a 10.1161/STROKEAHA.107.507475
|9 -- missing cx lookup --
|2 Crossref
|o 10.1161/STROKEAHA.107.507475
999 C 5 |a 10.1111/j.1747-4949.2010.00552.x
|9 -- missing cx lookup --
|2 Crossref
|o 10.1111/j.1747-4949.2010.00552.x
999 C 5 |a 10.1093/brain/awr169
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/brain/awr169
999 C 5 |a 10.1016/j.neurobiolaging.2008.09.001
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.neurobiolaging.2008.09.001
999 C 5 |a 10.1038/nrneurol.2009.215
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nrneurol.2009.215
999 C 5 |a 10.3174/ajnr.A3639
|9 -- missing cx lookup --
|2 Crossref
|o 10.3174/ajnr.A3639
999 C 5 |a 10.1016/j.neuroimage.2008.07.049
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.neuroimage.2008.07.049
999 C 5 |a 10.1016/S1474-4422(11)70307-6
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/S1474-4422(11)70307-6
999 C 5 |a 10.1016/j.jns.2012.05.052
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.jns.2012.05.052
999 C 5 |a 10.1148/radiol.2452060445
|9 -- missing cx lookup --
|2 Crossref
|o 10.1148/radiol.2452060445
999 C 5 |a 10.1016/j.bbadis.2011.04.008
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.bbadis.2011.04.008
999 C 5 |a 10.1016/j.nicl.2015.02.003
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.nicl.2015.02.003
999 C 5 |a 10.1002/0470869526.ch18
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/0470869526.ch18
999 C 5 |a 10.1093/brain/awt184
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/brain/awt184
999 C 5 |a 10.1016/S0887-6177(03)00039-8
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/S0887-6177(03)00039-8
999 C 5 |a 10.1186/1471-2377-11-29
|9 -- missing cx lookup --
|2 Crossref
|o 10.1186/1471-2377-11-29
999 C 5 |a 10.1037/1040-3590.18.4.424
|9 -- missing cx lookup --
|2 Crossref
|o 10.1037/1040-3590.18.4.424
999 C 5 |a 10.1017/S0033291707000360
|9 -- missing cx lookup --
|2 Crossref
|o 10.1017/S0033291707000360
999 C 5 |a 10.1186/s12883-014-0254-4
|9 -- missing cx lookup --
|2 Crossref
|o 10.1186/s12883-014-0254-4
999 C 5 |a 10.1111/j.1365-2796.2004.01388.x
|9 -- missing cx lookup --
|2 Crossref
|o 10.1111/j.1365-2796.2004.01388.x
999 C 5 |a 10.1016/j.neurobiolaging.2014.09.013
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.neurobiolaging.2014.09.013
999 C 5 |a 10.1016/j.neuroimage.2004.07.051
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.neuroimage.2004.07.051
999 C 5 |a 10.1016/j.neuroimage.2010.06.014
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.neuroimage.2010.06.014
999 C 5 |a 10.1016/j.neuroimage.2006.02.024
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.neuroimage.2006.02.024
999 C 5 |y 2014
|2 Crossref
|t A language and environment for statistical computing
|o R Core Team A language and environment for statistical computing 2014
999 C 5 |2 Crossref
|o
999 C 5 |a 10.1109/TSMC.1979.4310076
|9 -- missing cx lookup --
|2 Crossref
|o 10.1109/TSMC.1979.4310076
999 C 5 |y 1980
|2 Crossref
|t Introduction to bivariate and multivariate analysis
|o Lindeman Introduction to bivariate and multivariate analysis 1980
999 C 5 |a 10.18637/jss.v017.i01
|9 -- missing cx lookup --
|2 Crossref
|o 10.18637/jss.v017.i01
999 C 5 |a 10.3758/BF03193146
|9 -- missing cx lookup --
|2 Crossref
|o 10.3758/BF03193146
999 C 5 |a 10.1161/STROKEAHA.110.609768
|9 -- missing cx lookup --
|2 Crossref
|o 10.1161/STROKEAHA.110.609768
999 C 5 |a 10.1161/STROKEAHA.112.680223
|9 -- missing cx lookup --
|2 Crossref
|o 10.1161/STROKEAHA.112.680223
999 C 5 |a 10.1371/journal.pone.0061014
|9 -- missing cx lookup --
|2 Crossref
|o 10.1371/journal.pone.0061014
999 C 5 |a 10.1002/ana.23802
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/ana.23802
999 C 5 |a 10.3233/JAD-2012-120784
|9 -- missing cx lookup --
|2 Crossref
|o 10.3233/JAD-2012-120784
999 C 5 |a 10.1161/01.STR.0000189696.70989.a4
|9 -- missing cx lookup --
|2 Crossref
|o 10.1161/01.STR.0000189696.70989.a4
999 C 5 |a 10.1161/01.STR.0000041681.25514.22
|9 -- missing cx lookup --
|2 Crossref
|o 10.1161/01.STR.0000041681.25514.22
999 C 5 |a 10.1016/j.neuroimage.2011.08.043
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.neuroimage.2011.08.043
999 C 5 |a 10.1016/j.neuroimage.2014.01.031
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.neuroimage.2014.01.031
999 C 5 |a 10.1002/nbm.3269
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/nbm.3269
999 C 5 |y 2003
|2 Crossref
|o Cercignani 2003
999 C 5 |a 10.1371/journal.pone.0097173
|9 -- missing cx lookup --
|2 Crossref
|o 10.1371/journal.pone.0097173
999 C 5 |a 10.1038/nrneurol.2015.10
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nrneurol.2015.10
999 C 5 |a 10.1038/jcbfm.2015.113
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/jcbfm.2015.113


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21